Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
Часто задаваемые вопросы
В каком секторе работает Co-Diagnostics Inc (CODX)?
Co-Diagnostics Inc относится к сектору Здравоохранение.
Какова текущая цена акций Co-Diagnostics Inc (CODX)?
По последним данным, цена акций Co-Diagnostics Inc составляет 0,27 $, предыдущее закрытие — 0,36 $. За последнюю торговую сессию акции Co-Diagnostics Inc снизились на -0,09 $, что соответствует падению на -26,09%.
Выплачивает ли Co-Diagnostics Inc (CODX) дивиденды?
Нет, Co-Diagnostics Inc не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у Co-Diagnostics Inc (CODX)?
У компании Co-Diagnostics Inc бета 2.880, что свидетельствует о крайне высокой волатильности по сравнению с рынком
